Available On Demand
As U.S. leaders promote a drug pricing vision based on Most-Favored Nation (MFN) principles, ensuring that U.S. consumers have access to the best available prices among advanced nations, pharmaceutical companies are facing increased uncertainty and are evaluating strategic options.
This session will bring together Trinity experts to discuss how this initiative could realistically lead to changes in the market, including voluntary industry action, agency rulemaking, new legislation, and how these decisions may affect both U.S. and international markets. We will also examine the influence of MFN implementation on launch sequencing and pricing strategies across markets, highlighting the importance of timely and effective strategy and communication.
Designed for industry executives and professionals involved in pricing, market access, strategy, and policy, this webinar will help you anticipate regulatory change and adjust to evolving global dynamics.
Key Webinar Topics
- Clarify the debate over list price vs. net price in MFN principles and its implications for strategy.
- Assess potential impacts on global markets, including effects on ex-U.S. pricing policy and launch approach.
- Evaluate implications for commercial and go-to-market strategy across existing portfolios and new assets.
- Identify effective approaches to internal and external communication in a period of policy uncertainty.
Complete the form below to view the on-demand webinar:
By clicking "I agree" above, you are agreeing that Trinity will use and protect your personal data in accordance with our Privacy Policy. You can opt out of future marketing communications at any time by clicking the unsubscribe link at the bottom of any marketing email you receive from Trinity.